Influence of short-term glucocorticoid therapy on regulatory T cells in vivo
- PMID: 21912688
- PMCID: PMC3166315
- DOI: 10.1371/journal.pone.0024345
Influence of short-term glucocorticoid therapy on regulatory T cells in vivo
Abstract
Background: Pre- and early clinical studies on patients with autoimmune diseases suggested that induction of regulatory T(T(reg)) cells may contribute to the immunosuppressive effects of glucocorticoids (GCs).
Objective: We readdressed the influence of GC therapy on T(reg) cells in immunocompetent human subjects and naïve mice.
Methods: Mice were treated with increasing doses of intravenous dexamethasone followed by oral taper, and T(reg) cells in spleen and blood were analyzed by FACS. Sixteen patients with sudden hearing loss but without an inflammatory disease received high-dose intravenous prednisolone followed by stepwise dose reduction to low oral prednisolone. Peripheral blood T(reg) cells were analyzed prior and after a 14 day GC therapy based on different markers.
Results: Repeated GC administration to mice for three days dose-dependently decreased the absolute numbers of T(reg) cells in blood (100 mg dexamethasone/kg body weight: 2.8±1.8×10(4) cells/ml vs. 33±11×10(4) in control mice) and spleen (dexamethasone: 2.8±1.9×10(5)/spleen vs. 95±22×10(5)/spleen in control mice), which slowly recovered after 14 days taper in spleen but not in blood. The relative frequency of FOXP3(+) T(reg) cells amongst the CD4(+) T cells also decreased in a dose dependent manner with the effect being more pronounced in blood than in spleen. The suppressive capacity of T(reg) cells was unaltered by GC treatment in vitro. In immunocompetent humans, GCs induced mild T cell lymphocytosis. However, it did not change the relative frequency of circulating T(reg) cells in a relevant manner, although there was some variation depending on the definition of the T(reg) cells (FOXP3(+): 4.0±1.5% vs 3.4±1.5%*; AITR(+): 0.6±0.4 vs 0.5±0.3%, CD127(low): 4.0±1.3 vs 5.0±3.0%* and CTLA4+: 13.8±11.5 vs 15.6±12.5%; * p<0.05).
Conclusion: Short-term GC therapy does not induce the hitherto supposed increase in circulating T(reg) cell frequency, neither in immunocompetent humans nor in mice. Thus, it is questionable that the clinical efficacy of GCs is achieved by modulating T(reg) cell numbers.
Conflict of interest statement
Figures
Similar articles
-
Expression profiles of regulatory and helper T-cell-associated genes in nasal polyposis.Allergy. 2012 Jun;67(6):732-40. doi: 10.1111/j.1398-9995.2012.02811.x. Epub 2012 Mar 30. Allergy. 2012. PMID: 22462754
-
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.J Allergy Clin Immunol. 2004 Dec;114(6):1425-33. doi: 10.1016/j.jaci.2004.07.014. J Allergy Clin Immunol. 2004. PMID: 15577848
-
Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.Immunobiology. 2019 Mar;224(2):285-295. doi: 10.1016/j.imbio.2018.12.002. Epub 2018 Dec 27. Immunobiology. 2019. PMID: 30612787
-
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review.
-
CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.Semin Cancer Biol. 2006 Apr;16(2):150-9. doi: 10.1016/j.semcancer.2005.11.008. Epub 2006 Jan 23. Semin Cancer Biol. 2006. PMID: 16431128 Review.
Cited by
-
Role of Peripheral Regulatory T Lymphocytes in Patients with Thyroid Associated Ophthalmopathy During Systemic Glucocorticoid Treatment: A Prospective Observational Study.Curr Med Sci. 2023 Feb;43(1):130-138. doi: 10.1007/s11596-022-2671-8. Epub 2022 Dec 2. Curr Med Sci. 2023. PMID: 36459302
-
Ecoimmunology in the field: Measuring multiple dimensions of immune function with minimally invasive, field-adapted techniques.Am J Hum Biol. 2022 Nov;34(11):e23784. doi: 10.1002/ajhb.23784. Epub 2022 Jul 21. Am J Hum Biol. 2022. PMID: 35861267 Free PMC article. Review.
-
Regulatory T cell function in autoimmune disease.J Transl Autoimmun. 2021 Oct 30;4:100130. doi: 10.1016/j.jtauto.2021.100130. eCollection 2021. J Transl Autoimmun. 2021. PMID: 35005594 Free PMC article. Review.
-
Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD.Front Immunol. 2021 Oct 11;12:716629. doi: 10.3389/fimmu.2021.716629. eCollection 2021. Front Immunol. 2021. PMID: 34707604 Free PMC article.
-
Relationship between CCR5+FoxP3+ Treg cells and forced expiratory volume in 1 s, peak expiratory flow in patients with severe asthma.Postepy Dermatol Alergol. 2021 Apr;38(2):262-268. doi: 10.5114/ada.2021.106202. Epub 2021 May 22. Postepy Dermatol Alergol. 2021. PMID: 34408594 Free PMC article.
References
-
- Norgaard P, Poulsen HS. Glucocorticoid receptors in human malignancies: a review. Ann Oncol. 1991;2:541–557. - PubMed
-
- Zanchi NE, Filho MA, Felitti V, Nicastro H, Lorenzeti FM, et al. Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation. J Cell Physiol. 2010;224:311–315. - PubMed
-
- Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, et al. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol. 1993;14:303–347. - PubMed
-
- Gaillard RC. Interaction between the hypothalamo-pituitary-adrenal axis and the immunological system. Ann Endocrinol (Paris) 2001;62:155–163. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous